Grandfield & Dodd’s Pfizer PFE Stock Holding History

Grandfield & Dodd’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Sell	49,046 -14,034	-22%	-$374K	0.08%	100
2025 Q4	$1.57M	Sell	63,080 -2,611	-4%	-$65.8K	0.09%	98
2025 Q3	$1.67M	Sell	65,691 -99	-0.2%	-$2.44K	0.1%	95
2025 Q2	$1.59M	Sell	65,790 -2,516	-4%	-$58.7K	0.09%	95
2025 Q1	$1.73M	Sell	68,306 -868	-1%	-$22.7K	0.11%	90
2024 Q4	$1.84M	Sell	69,174 -1,018	-1%	-$27.6K	0.11%	91
2024 Q3	$2.03M	Sell	70,192 -69	-0.1%	-$2.01K	0.12%	83
2024 Q2	$1.97M	Sell	70,261 -5,356	-7%	-$147K	0.12%	82
2024 Q1	$2.1M	Buy	75,617 +301	+0.4%	+$8.35K	0.13%	80
2023 Q4	$2.17M	Sell	75,316 -13,478	-15%	-$407K	0.15%	74
2023 Q3	$2.95M	Buy	88,794 +13,756	+18%	+$486K	0.22%	66
2023 Q2	$2.75M	Sell	75,038 -4,666	-6%	-$182K	0.19%	70
2023 Q1	$3.25M	Buy	79,704 +100	+0.1%	+$4.32K	0.23%	69
2022 Q4	$4.08M	Sell	79,604 -3,090	-4%	-$148K	0.3%	64
2022 Q3	$3.62M	Buy	82,694 +4,993	+6%	+$243K	0.3%	63
2022 Q2	$4.07M	Sell	77,701 -485	-0.6%	-$24.7K	0.32%	60
2022 Q1	$4.05M	Sell	78,186 -4,868	-6%	-$253K	0.27%	66
2021 Q4	$4.9M	Sell	83,054 -2,025	-2%	-$100K	0.32%	61
2021 Q3	$3.66M	Buy	85,079 +14,063	+20%	+$623K	0.26%	66
2021 Q2	$2.78M	Buy	71,016 +579	+0.8%	+$22.5K	0.19%	68
2021 Q1	$2.55M	Buy	70,437 +363	+0.5%	+$12.9K	0.19%	67
2020 Q4	$2.58M	Sell	70,074 -3,154	-4%	-$116K	0.2%	68
2020 Q3	$2.55M	Sell	73,228 -5,902	-7%	-$207K	0.23%	68
2020 Q2	$2.45M	Buy	79,130 +757	+1%	+$25.7K	0.24%	68
2020 Q1	$2.43M	Sell	78,373 -7,950	-9%	-$271K	0.29%	65
2019 Q4	$3.21M	Buy	86,323 +597	+0.7%	+$21.3K	0.29%	66
2019 Q3	$2.92M	Buy	85,726 +580	+0.7%	+$21.1K	0.29%	66
2019 Q2	$3.5M	Sell	85,146 -148	-0.2%	-$5.88K	0.35%	62
2019 Q1	$3.44M	Buy	85,294 +148	+0.2%	+$5.93K	0.36%	62
2018 Q4	$3.53M	Hold	85,146	–	–	0.42%	59
2018 Q3	$3.56M	Sell	85,146 -41	-0%	-$1.58K	0.37%	66
2018 Q2	$2.93M	Buy	85,187 +141	+0.2%	+$4.82K	0.32%	67
2018 Q1	$2.86M	Sell	85,046 -724	-0.8%	-$24.9K	0.32%	67
2017 Q4	$2.95M	Sell	85,770 -527	-0.6%	-$18K	0.31%	67
2017 Q3	$2.92M	Sell	86,297 -1,079	-1%	-$34.7K	0.33%	66
2017 Q2	$2.79M	Sell	87,376 -348	-0.4%	-$11K	0.33%	68
2017 Q1	$2.85M	Buy	87,724 +263	+0.3%	+$8.29K	0.35%	66
2016 Q4	$2.69M	Buy	87,461 +165	+0.2%	+$5.04K	0.35%	67
2016 Q3	$2.81M	Buy	87,296 +134	+0.2%	+$4.48K	0.37%	63
2016 Q2	$2.91M	Hold	87,162	–	–	0.41%	61
2016 Q1	$2.45M	Buy	87,162 +942	+1%	+$26.9K	0.35%	60
2015 Q4	$2.64M	Hold	86,220	–	–	0.4%	60
2015 Q3	$2.57M	Hold	86,220	–	–	0.43%	58
2015 Q2	$2.74M	Buy	86,220 +816	+1%	+$26.6K	0.42%	59
2015 Q1	$2.82M	Hold	85,404	–	–	0.43%	59
2014 Q4	$2.52M	Sell	85,404 -1,487	-2%	-$42.6K	0.39%	59
2014 Q3	$2.44M	Buy	86,891 +58	+0.1%	+$1.63K	0.38%	63
2014 Q2	$2.44M	Sell	86,833 -1,520	-2%	-$43.3K	0.37%	67
2014 Q1	$2.69M	Buy	88,353 +8,432	+11%	+$251K	0.42%	61
2013 Q4	$2.32M	Sell	79,921 -420	-0.5%	-$12.2K	0.38%	61
2013 Q3	$2.19M	Sell	80,341 -714	-0.9%	-$19.4K	0.39%	63
2013 Q2	$2.15M	Buy	+81,055	New	+$2.24M	0.41%	62

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Grandfield & Dodd's PFE Position: Q1 2026 in Review

Grandfield & Dodd reduced its Pfizer (PFE) stake by 22% in Q1 2026, selling an estimated $374K and leaving 49,046 shares worth $1.38M. The position accounts for 0.08% of the portfolio, ranked #100.

Grandfield & Dodd first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.9M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Grandfield & Dodd held 49,046 shares of Pfizer worth $1.38M as of Q1 2026.
Grandfield & Dodd sold 14,034 Pfizer shares in Q1 2026, an estimated $374K.
Pfizer made up 0.08% of Grandfield & Dodd's portfolio in Q1 2026, its #100 holding.
Grandfield & Dodd first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Grandfield & Dodd's Pfizer position peaked at $4.9M in Q4 2021.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.